Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor

Technology appraisal guidance
Reference number: TA195
Published: 25 August 2010

Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: Appendix A - decision paper presented to the Institute's Guidance Executive

Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: Appendix A - decision paper presented to the Institute's Guidance Executive

Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: Appendix A - decision paper presented to the Institute's Guidance Executive
16 September 2013
(225.79 Kb 5 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 13 September 2013